2009 Form 990-PF - Bill & Melinda Gates Foundation

BILL & MELINDA GATES FOUNDATION 56-2618866
FORM 990PF, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR
RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR
AND
ATTACHMENT 18 (CONT'D)
RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT
MINNESOTA PUBLIC RADIO NONE TO STRENGTHEN THE QUALITY AND QUANTITY OF
301,768.
480 CEDAR ST 509(A)(1)
ST PAUL, MN 55101
REPORTING ON ISSUES RELATED TO THE NATION'S
LOW COLLEGE COMPLETION RATES
MINORITY EXEC DIR COALITION KING CO NONE FOR GENERAL OPERATING SUPPORT
5,000.
PO BOX 3064 509(A)(1)
SEATTLE, WA 98114
MISSOURI STATE LIBRARY NONE TO IMPROVE TECHNOLOGY ACCESS IN LIBRARIES
664,032.
600 WEST MAIN STREET 170(C)(1)
JEFFERSON CITY, MO 65102
SERVING LOW-INCOME PATRONS AND ESTABLISH
SUSTAINABLE LOCAL FUNDING TO SUPPORT THE
ONGOING PROVISION OF THIS SERVICE
MOCKINGBIRD SOCIETY NONE TO SUPPORT A FOSTER YOUTH LEADERSHIP PROGRAM
135,000.
2100 24TH AVE S 509(A)(1)
SUITE 240
SEATTLE, WA 98144
MOLECMO NANOBIOTECHNOLOGIES NONE "TARGETING THE INTRACELLULAR TRANSPORT OF HIV AS
89,766.
137 BUSSEY STREET US NON-EXEMPT
SUITE 1
DEDHAM, MA 02026
A NOVEL ANTIVIRAL APPROACH"ALI MUNAWAR OF MOLECMO
NANOBIOTECHNOLOGIES IN THE U.S. AIMS TO IDENTIFY
THE SPECIFIC PROTEIN THAT ENABLES THE HIV VIRUS
TO ACCESS VARIOUS SITES WITHIN THE HOST CELL FOR
REPLICATION. IDENTIFICATION OF THIS PROTEIN WILL
ADVANCE THE DEVELOPMENT OF A NOVEL CLASS OF SMALL
MOLECULE INHIBITORS THAT DISRUPT THE HIV LIFE
MONASH UNIVERSITY NONE 100,000.
FOR PUBLIC DISCLOSURE
161 OF 519
CYCLE.
AUSTRALIA WILL DESIGN A NOVEL VACCINE PLATFORM
BASED ON PROTEIN MICROCRYSTALS PRODUCED BY
INSECT VIRUSES. COULIBALY WILL ENGINEER
VACCINES THAT UTILIZE THIS STABLE STRUCTURE TO
ATTACHMENT 18